The UK Life Sciences Council, a twice-yearly meeting between ministers and global life sciences industry leaders, met on Thursday 25th May to discuss the sector’s economic
Primary care doctors in the UK are a “negligible” provider of commercial clinical trial activity and should be incentivised to give experimental therapies to patients.
As the Association of the British Pharmaceutical Industry (ABPI) announces that Susan Rienow, UK managing director and country president of Pfizer, is formally taking on the role of preside
Attending this year’s Association of British Pharmaceutical Industry (ABPI) Conference in London on Thursday 27th April, it quickly became clear that the day would be a notable one – not ju
The UK’s voluntary system of revenue rebates to limit rises in medicines spending is already causing deep upset among branded drug manufacturers as clawbacks rise.
The Association of the British Pharmaceutical Industry (ABPI) has added five new patient organisation figures to its patient advisory council, set up to provide patient pe